Kalos Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-165
| Closed | -$26.3K | – | 132 |
|
|
2023
Q1 | $26.3K | Buy |
+165
| New | +$26.3K | 0.05% | 128 |
|
|
2022
Q3 | – | Sell |
-4,325
| Closed | -$664K | – | 43 |
|
|
2022
Q2 | $664K | Sell |
4,325
-652
| -13% | -$100K | 0.89% | 28 |
|
|
2022
Q1 | $806K | Sell |
4,977
-12,938
| -72% | -$2.1M | 0.55% | 40 |
|
|
2021
Q4 | $2.07M | Buy |
17,915
+521
| +3% | +$60.3K | 0.56% | 38 |
|
|
2021
Q3 | $2.01M | Buy |
17,394
+14,622
| +527% | +$1.69M | 0.57% | 35 |
|
|
2021
Q2 | $315K | Sell |
2,772
-117
| -4% | -$13.3K | 0.13% | 187 |
|
|
2021
Q1 | $327K | Sell |
2,889
-358
| -11% | -$40.5K | 0.1% | 207 |
|
|
2020
Q4 | $344K | Buy |
3,247
+98
| +3% | +$10.4K | 0.15% | 167 |
|
|
2020
Q3 | $297K | Buy |
3,149
+137
| +5% | +$12.9K | 0.13% | 172 |
|
|
2020
Q2 | $288K | Buy |
+3,012
| New | +$288K | 0.12% | 159 |
|
|
2018
Q1 | – | Sell |
-7,974
| Closed | -$778K | – | 128 |
|
|
2017
Q4 | $778K | Buy |
7,974
+637
| +9% | +$62.2K | 0.37% | 78 |
|
|
2017
Q3 | $652K | Buy |
7,337
+287
| +4% | +$25.5K | 0.42% | 71 |
|
|
2017
Q2 | $511K | Sell |
7,050
-545
| -7% | -$39.5K | 0.47% | 62 |
|
|
2017
Q1 | $495K | Buy |
7,595
+351
| +5% | +$22.9K | 0.35% | 74 |
|
|
2016
Q4 | $454K | Sell |
7,244
-1,542
| -18% | -$96.6K | 0.37% | 72 |
|
|
2016
Q3 | $554K | Sell |
8,786
-774
| -8% | -$48.8K | 0.47% | 67 |
|
|
2016
Q2 | $592K | Sell |
9,560
-632
| -6% | -$39.1K | 0.46% | 74 |
|
|
2016
Q1 | $603K | Buy |
10,192
+402
| +4% | +$23.8K | 0.5% | 65 |
|
|
2015
Q4 | $725K | Buy |
+9,790
| New | +$725K | 0.54% | 61 |
|